Immunogenicity and Safety According to Immunosuppressive Drugs and Different COVID-19 Vaccine Platforms in Immune-Mediated Disease: Data from SAFER Cohort. - Machado KLLL; Burian APN; Martins-Filho OA; Mill JG; Ferreira LB; Tapia KRL; Moulin ACS; Moulaz IR; Ribeiro PDC; Magalhães VO; Biegelmeyer E; Peixoto FMMMC; et al. (Vaccines, 2024)